"The abortion opponents who are seeking to convince the U.S. Supreme Court to limit access to the abortion pill mifepristone point to three studies by Gynuity Health Projects, a New York-based women's health research group, to back up their arguments that it is unsafe despite its regulatory approval decades ago.
But the way the research has been prominently cited by the plaintiffs in their bid to limit how the pill is prescribed and distributed is bewildering to Dr. Beverly Winikoff, Gynuity's president, given that the conclusions broadly support easier access to the medication.
"They live on a different planet," Winikoff said of the plaintiffs during an interview at her Midtown Manhattan office. "You can always distort information and say things that aren'ttrue."
The Supreme Court, whose conservative majority in 2022 overturned the landmark 1973 Roe v. Wade ruling that had recognized a constitutional right to abortion, is set to hear arguments in the case on Tuesday."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.